{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Pharmacy2Home%2FLandiCom%20Holding%20LTD","name":"Pharmacy2Home/LandiCom Holding LTD","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T09:27:08.467Z"},"count":1,"matches":[{"id":"78af2f99d71e7a93","posted_date":"2022-02-15","letter_issue_date":"2022-02-03","company_name":"Pharmacy2Home/LandiCom Holding LTD","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)","canonical_url":"https://api.morvs.ai/fda-warning/78af2f99d71e7a93"}]}